We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pozen, Teva Agree to Settlement in Treximet Patent Litigation
Pozen, Teva Agree to Settlement in Treximet Patent Litigation
April 27, 2010
Pozen and Teva Pharmaceuticals USA have settled patent litigation over Teva’s ANDA for a generic version of migraine drug Treximet.